Contents:

Wound Treatments in Hong Kong, China Euromonitor International April 2009 List of Contents and Tables Executive Summary OTC Healthcare Enjoys Good Growth Pain Relief - the Hottest Topic in 2008 Intense Competition Chemists/pharmacies Remain the Most Popular Choice OTC Healthcare To Continue Growing Key Trends and Developments Blurring Boundaries Between OTC and Cosmetics Products Revival of Traditional Chinese Medicine and Herbal Remedies Tourists Boosting Sales of OTC Products Consumers Have More Confidence To Self-medicate for Minor Ailments Child-specific OTC Healthcare Sales Still Small Market Indicators Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008 Table 2 Life Expectancy at Birth 2003-2008 Market Data Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008 Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008 Table 5 OTC Healthcare Company Shares by Value 2004-2008 Table 6 OTC Healthcare Brand Shares by Value 2005-2008 Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008 Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008 Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013 Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013 Appendix OTC Registration and Classification Vitamins & Dietary Supplements Registration and Classification Self-medication and Preventative Medicine Generics Switches Definitions Summary 1 Research Sources Fei Fah Medibalm (hk) Co Strategic Direction Key Facts Summary 2 Fei Fah Medibalm (HK) Co: Key Facts Company Background Production Competitive Positioning Summary 3 Fei Fah Medibalm (HK) Co: Competitive Position 2007 Fortune Pharmacal Co Ltd Strategic Direction Key Facts Summary 4 Fortune Pharmacal Co Ltd: Key Facts Company Background Prodution Competitive Positioning Summary 5 Fortune Pharmacal Co Ltd: Competitive Position 2007 Hoe Hin Pak Fah Yeow Manufacturing Ltd Strategic Direction Key Facts Summary 6 Hoe Hin Pak Fah Yeow Manufacturing Ltd: Key Facts Summary 7 Hoe Hin Pak Fah Yeow Manufactory Ltd: Operational Indicators Company Background Production Competitive Positioning Summary 8 Hoe Hin Pak Fah Yeow Manufacturing Ltd: Competitive Position 2007 Nin Jiom Medicine Mfy (hong Kong) Ltd Strategic Direction Key Facts Summary 9 Nin Jiom Medicine Mfy (Hong Kong) Ltd: Key Facts Company Background Production Competitive Positioning Summary 10 Nin Jiom Medicine Mfy (Hong Kong) Ltd: Competitive Position 2007 Wai Yuen Tong Medicine Holdings Ltd Strategic Direction Key Facts Summary 11 Wai Yuen Tong Medicine Holding Ltd: Key Facts Summary 12 Wai Yuen Tong Medicine Holding Ltd: Operational Indicators Company Background Production Competitive Positioning Summary 13 Wai Yuen Tong Medicine Holding Ltd: Competitive Position 2007 Sector Data Table 11 Sales of Wound Treatments by Subsector: Value 2003-2008 Table 12 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008 Table 13 Wound Treatments Company Shares by Value 2004-2008 Table 14 Wound Treatments Brand Shares by Value 2005-2008 Table 15 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013 Table 16 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013

Summary:

GlaxoSmithKline HK Ltd remained the leading player in fragmented OTC Healthcare in 2005 OTC healthcare is fragmented with a wide variety of brands for consumers to choose from and it is difficult for companies to stand out amongst the numerous players that are present and to gain consumer support for their brands. However, GlaxoSmithKline HK Ltd succeeded in retaining its leading position in OTC Healthcare over the review period, to achieve a value share of 10% in 2005. The company has gained popularity through its extensive product range and aggressive marketing through major media channels. It has also frequently renewed the packaging of various products in order to refresh consumers’ perceptions and maintain product awareness. Although consumers are generally loyal to brands in OTC Healthcare, it is important to maintain brand awareness in this fragmented environment.

Companies Mentioned

Companies Mentioned Include: - Puritan's Pride Inc - GlaxoSmithKline HK Ltd - Cerebos Pacific Pte Ltd - Wyeth (HK) Ltd - Fortune Pharmacal Co Ltd - Eu Yan Sang (Hong Kong) Ltd - Pfizer Corp Hong Kong Ltd - Roche Hong Kong Ltd - Nin Jiom Medicine Mfy (Hong Kong) Ltd - Novartis Pharmaceuticals (HK) Ltd - Advance Pharmaceutical Co Ltd - Ricola AG - Shigaken Pharmaceutical Ind Co - Boots Co Plc, The - Smith & Nephew Ltd - Johnson & Johnson HK Ltd - Kendall Co, The - AstraZeneca Hong Kong Ltd - Vita Green Health Products Co Ltd - Abbott Laboratories Ltd - Lofthouse of Fleetwood Ltd - ICN Pharmaceutical Inc - Reckitt Benckiser HK Ltd - Mentholatum (Asia Pacific) Ltd - Haw Par Healthcare Ltd - Hoe Hin Pak Fah Yeow Manufacturing Ltd - Boehringer Ingelheim (Hong Kong) Ltd - Aventis Pharma Ltd - Chattem Inc - Bayer Healthcare Co Ltd - 3M Hong Kong Ltd - Bristol-Myers Squibb (HK) Ltd - Beiersdorf AG - Ryson Ltd - Takeda Chemical Industries Ltd - Blackmores Ltd - Pharmacia Asia Ltd - Pharmacia Asia Ltd - Whitehall Laboratories